For prescribing information, click here

This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Resources

Adult Spasticity

Adult Spasticity - Resources
Adult Spasticity - Resources

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) therapeutic indications

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) is indicated for symptomatic treatment of focal spasticity of:

  • Upper limbs in adults
  • Lower limbs in adults affecting the ankle joint

Please click here to see the full therapeutic indications.

Product Resources

Injection Handbook – Adult Spasticity
Injection Handbook – Adult Spasticity
PDF / PowerPoint Deck 30 pages

A reference guide to the administration of Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) for the treatment of adult focal spasticity, including the identification of muscles using ultrasound, and the recommended injection technique per muscle.

DYS-UK-009017 | November 2024
Dose Map for Adult Focal Spasticity
Dose Map for Adult Focal Spasticity
PDF / PowerPoint Deck 3 pages

A downloadable reference guide to the dosing of Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) for the treatment of adult focal spasticity.

DYS-UK-009009 | November 2024
Dilution Guide
Dilution Guide
PDF / PowerPoint Deck 2 pages

A reference guide to reconstituting and diluting Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009018 | November 2024
Reconstitution Guide
Reconstitution Guide
Video 10:03

How to prepare, reconstitute and store Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009047 | November 2024
Mechanism of Action of Botulinum Neurotoxin Type A
Mechanism of Action of Botulinum Neurotoxin Type A
Video 3:13

Short animation explaining the mechanism of action of botulinum neurotoxin type A

DYS-UK-009022 | November 2024

eLearning

Management of Spasticity in Adults – eLearning Module
Management of Spasticity in Adults – eLearning Module
PDF / PowerPoint Deck 43 pages

An overview of the management of adult spasticity with a focus on the principles of spasticity and upper motor neurone syndrome pathophysiology​, the harmful effects of adult spasticity, and management​ and treatment options.

DYS-UK-009010 | November 2024
Patient Considerations & Goal Setting – eLearning Module
Patient Considerations & Goal Setting – eLearning Module
PDF / PowerPoint Deck 43 pages

Patient considerations in spasticity management and an introduction to goal setting with a focus on the patient’s perspective and Goal Attainment Scaling (GAS).

DYS-UK-009011 | November 2024
Diagnosis and assessment of spasticity in adults – eLearning Module
Diagnosis and assessment of spasticity in adults – eLearning Module
PDF / PowerPoint Deck 38 pages

An introduction to spasticity diagnosis and assessment with a focus on functional anatomy and impairment in spasticity, range of motion and mobility.

DYS-UK-009012 | November 2024
Management of spasticity with BoNT-A – eLearning Module
Management of spasticity with BoNT-A – eLearning Module
PDF / PowerPoint Deck 30 pages

An introduction to botulinum toxin with an overview of the mechanism of action of botulinum toxin type A, patient selection and Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) for the treatment of adult spasticity.

DYS-UK-009013 | November 2024
Clinical Trial Data for Dysport<sup>®</sup> (Clostridium botulinum type A toxin-haemagglutinin complex) – eLearning Module
Clinical Trial Data for Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) – eLearning Module
PDF / PowerPoint Deck 36 pages

An overview of the Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) clinical trial programme for spasticity in the upper and lower limb and real-life studies for botulinum toxin type A for spasticity upper and lower limb.

DYS-UK-009014 | November 2024
Flexibility in Clinical Practice: A case study (53M with Focal Spasticity)
Flexibility in Clinical Practice: A case study (53M with Focal Spasticity)
Video 8:47

Presented by: Dr Ganesh Bavikatte

DYS-UK-009027 | November 2024
Clinical case study: 23-year-old male with focal spasticity
Clinical case study: 23-year-old male with focal spasticity
Video 9:17

Dr Clive Bezzina explains his approach to treating a 23-year-old male with focal spasticity with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009025 | November 2024
Clinical case study: 75-year-old female with focal spasticity
Clinical case study: 75-year-old female with focal spasticity
Video 5:44

Dr Clive Bezzina explains his approach to treating a 75-year-old female with focal spasticity with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009024 | November 2024
Ultrasound Essentials – Introduction
Ultrasound Essentials – Introduction
Video 10:37

How to use ultrasound to identify muscles in the upper and lower limb, to assist the administration of Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) via intramuscular injection.

DYS-UK-009134 | November 2024
Ultrasound Essentials – Shoulder
Ultrasound Essentials – Shoulder
Video 16:16

How to identify muscles of the shoulder using ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) .

DYS-UK-009153 | November 2024
Ultrasound Essentials – Elbow
Ultrasound Essentials – Elbow
Video 13:40

How to identify the elbow flexor and extensor muscles using ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009154 | November 2024
Ultrasound Essentials – Forearm
Ultrasound Essentials – Forearm
Video 11:20

How to identify the forearm flexor and pronator muscles using ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009155 | November 2024
Ultrasound Essentials – Hand
Ultrasound Essentials – Hand
Video 13:20

How to identify the muscles of the thumb and hand using ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009156 | November 2024
Ultrasound Essentials – Lower Limb
Ultrasound Essentials – Lower Limb
Video 19:10

How to identify the muscles of the posterior lower leg and foot using ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009157 | November 2024
Concepts and Practical use of GAS (Goal Attainment Scale)
Concepts and Practical use of GAS (Goal Attainment Scale)
Video 36:41

Presented by: Dr Jorge Jacinto

DYS-UK-008951 | November 2024
Functional Anatomy of Adult Spasticity – Part 1
Functional Anatomy of Adult Spasticity – Part 1
Video 01:31:27

Spasticity patterns and anatomy of the upper arm, and the use of ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-008952 | November 2024
Functional Anatomy of Adult Spasticity – Part 2
Functional Anatomy of Adult Spasticity – Part 2
Video 01:22:47

Spasticity patterns and anatomy of the upper arm, and the use of ultrasound for injection with Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-008953 | November 2024

Talking Head Videos

Finding flexibility within Botulinum Toxin Clinics
Finding flexibility within Botulinum Toxin Clinics
Video 7:24

Dr Clive Bezzina discusses his experience of how Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) enabled his service to use a PIFU model.

DYS-UK-009023 | November 2024
A practical guide to implementing a flexible PIFU model
A practical guide to implementing a flexible PIFU model
Video 23:54

How the implementation of a Patient-Initiatied Follow-Up (PIFU) model may be a practical solution to capacity challenges and help achieve efficiency savings within BoNT-A services.

DYS-UK-008949 | November 2024
Making sense of the changing NHS and funding flows
Making sense of the changing NHS and funding flows
Video 12:15

Judy Willits discusses how the NHS payment scheme has evolved and what the changes could mean for your botulinum toxin services.

DYS-UK-008947 | November 2024
Demystifying the Clinical Relevance of BoNT Immunogenicity
Demystifying the Clinical Relevance of BoNT Immunogenicity
Video 6:00

Learn about the difference between neutralising and non-neutralising antibodies, and factors to consider when investigating non-response to BoNT treatment Presented by: Dr Tim Harrower

DYS-UK-009026 | November 2024

Contact your Ipsen representative

Send request
Resources